{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:57:57Z","timestamp":1791806277103,"version":"4.3.4"},"reference-count":227,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016619","name":"MyoKardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","award":["IMB-1018972"],"award-info":[{"award-number":["IMB-1018972"]}],"id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejase.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Echocardiography"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.echo.2022.03.012","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T16:51:29Z","timestamp":1654015889000},"page":"533-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":215,"title":["Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography"],"prefix":"10.1016","volume":"35","author":[{"given":"Sherif F.","family":"Nagueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind Y.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Dragulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasdet","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Mohiddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett W.","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.echo.2022.03.012_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","volume":"24","author":"Nagueh","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib2","first-page":"e23","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"162","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(99)00039-X","article-title":"Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities","volume":"33","author":"Maron","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jcmg.2018.02.002","article-title":"Myocardial stiffness evaluation using noninvasive shear wave imaging in healthy and hypertrophic cardiomyopathic adults","volume":"12","author":"Villemain","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCIMAGING.111.968859","article-title":"Exercise response in hypertrophic cardiomyopathy: blunted left ventricular deformational and twisting reserve with altered systolic-diastolic coupling","volume":"5","author":"Soullier","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001843","article-title":"Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy","volume":"8","author":"Pasqualucci","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.echo.2022.03.012_bib10","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2009.01.079","article-title":"Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study","volume":"54","author":"Sorajja","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib12","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib13","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context","volume":"67","author":"Sherrid","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.amjcard.2013.11.062","article-title":"Heart rate recovery in patients with hypertrophic cardiomyopathy","volume":"113","author":"Patel","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib15","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2016.07.751","article-title":"Mechanisms of myocardial ischemia in hypertrophic cardiomyopathy: insights from wave intensity analysis and magnetic resonance","volume":"68","author":"Raphael","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib16","doi-asserted-by":"crossref","first-page":"H1282","DOI":"10.1152\/ajpheart.00466.2019","article-title":"Hemodynamic effects of myocardial bridging in patients with hypertrophic cardiomyopathy","volume":"317","author":"Sharzehee","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.echo.2022.03.012_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy","volume":"119","author":"van Velzen","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jce.12982","article-title":"High incidence of de novo and subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac rhythm management device","volume":"27","author":"Wilke","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.echo.2022.03.012_bib19","doi-asserted-by":"crossref","first-page":"e003285","DOI":"10.1161\/CIRCIMAGING.115.003285","article-title":"T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study","volume":"8","author":"Hinojar","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.echo.2016.11.013","article-title":"Mechanical dispersion by strain echocardiography: a novel tool to diagnose hypertrophic cardiomyopathy in athletes","volume":"30","author":"Schnell","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","article-title":"Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics","volume":"19","author":"Williams","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2022.03.012_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.echo.2014.04.015","article-title":"Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy","volume":"27","author":"Phelan","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hrthm.2021.01.019","article-title":"Evolution of Risk Stratification and Sudden Death Prevention in Hypertrophic Cardiomyopathy: 20 Years with the Implantable Cardioverter-Defibrillator","volume":"18","author":"Maron","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.echo.2022.03.012_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib26","series-title":"Normal echocardiographic values for cardiovascular structures. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult","first-page":"883","author":"Colan","year":"2016"},{"key":"10.1016\/j.echo.2022.03.012_bib27","doi-asserted-by":"crossref","first-page":"e006979","DOI":"10.1161\/CIRCIMAGING.117.006979","article-title":"Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity: The Pediatric Heart Network Normal Echocardiogram Database","volume":"10","author":"Lopez","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib28","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib30","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.echo.2020.04.009","article-title":"Contrast-enhanced echocardiographic measurement of left ventricular wall thickness in hypertrophic cardiomyopathy: comparison with standard echocardiography and cardiac magnetic resonance","volume":"33","author":"Urbano-Moral","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib31","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.amjcard.2017.02.009","article-title":"Comparison of ventricular septal measurements in hypertrophic cardiomyopathy patients who underwent surgical myectomy using multimodality imaging and implications for diagnosis and management","volume":"119","author":"Phelan","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.echo.2012.12.015","article-title":"Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image","volume":"26","author":"Chang","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/echo.13096","article-title":"Utility of real time 3D echocardiography for the assessment of left ventricular mass in patients with hypertrophic cardiomyopathy: comparison with cardiac magnetic resonance","volume":"33","author":"Avegliano","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.echo.2022.03.012_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11886-017-0897-z","article-title":"Complementary role of echocardiography and cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"19","author":"Hindieh","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.echo.2022.03.012_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2022.03.012_bib37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/heartjnl-2015-309077","article-title":"Cardiac MRI evaluation of myocardial disease","volume":"102","author":"Captur","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/02841850600977760","article-title":"Quantification of global left ventricular function: comparison of multidetector computed tomography and magnetic resonance imaging. a meta-analysis and review of the current literature","volume":"47","author":"van der Vleuten","year":"2006","journal-title":"Acta Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib39","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00330-008-0982-1","article-title":"Global left-ventricular function assessment using dual-source multidetector CT: effect of improved temporal resolution on ventricular volume measurement","volume":"18","author":"Puesken","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib40","doi-asserted-by":"crossref","first-page":"e2194","DOI":"10.4244\/EIJ-D-15-00159","article-title":"Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"12","author":"Cooper","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.echo.2022.03.012_bib41","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.amjcard.2012.05.035","article-title":"Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy","volume":"110","author":"Rowin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib42","doi-asserted-by":"crossref","first-page":"e003454","DOI":"10.1161\/CIRCIMAGING.114.003454","article-title":"Clinical profile of athletes with hypertrophic cardiomyopathy","volume":"8","author":"Sheikh","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.echo.2020.02.009","volume":"33","author":"Baggish","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib44","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.jacc.2007.12.061","article-title":"Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy","volume":"51","author":"Basavarajaiah","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jamacardio.2015.0252","article-title":"Athletic cardiac remodeling in US professional basketball players","volume":"1","author":"Engel","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jcmg.2016.08.011","article-title":"Effect of sex and sporting discipline on LV adaptation to exercise","volume":"10","author":"Finocchiaro","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.echo.2017.11.022","article-title":"Role of Doppler diastolic parameters in differentiating physiological left ventricular hypertrophy from hypertrophic cardiomyopathy","volume":"31","author":"Finocchiaro","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib48","first-page":"1","article-title":"Evaluation of left ventricular outflow gradients during staged exercise stress echocardiography helps differentiate pediatric patients with hypertrophic cardiomyopathy from athletes and normal subjects","author":"Gaitonde","year":"2021","journal-title":"Pediatr Exerc Sci"},{"key":"10.1016\/j.echo.2022.03.012_bib49","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2016.02.054","article-title":"Assessing myocardial extracellular volume by t1 mapping to distinguish hypertrophic cardiomyopathy from athlete's heart","volume":"67","author":"Swoboda","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib50","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/clc.23360","article-title":"Myocardial fibrosis in athletes-Current perspective","volume":"43","author":"Malek","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/CIRCULATIONAHA.120.052573","article-title":"COVID-19 myocardial pathology evaluation in athletes with Cardiac Magnetic Resonance (COMPETE CMR)","volume":"143","author":"Clark","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib52","first-page":"557","article-title":"Detraining-related changes in left ventricular wall thickness and longitudinal strain in a young athlete likely to have hypertrophic cardiomyopathy","volume":"11","author":"de Gregorio","year":"2012","journal-title":"Journal of sports science & medicine"},{"key":"10.1016\/j.echo.2022.03.012_bib53","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2022.03.012_bib54","doi-asserted-by":"crossref","first-page":"e002877","DOI":"10.1161\/JAHA.115.002877","article-title":"Subtype-specific interactions and prognosis in cardiac amyloidosis","volume":"5","author":"Sperry","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.echo.2022.03.012_bib55","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.echo.2022.03.012_bib57","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","article-title":"Cardiac manifestations of Anderson-Fabry disease in heterozygous females","volume":"40","author":"Kampmann","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib58","doi-asserted-by":"crossref","first-page":"e000571","DOI":"10.1136\/openhrt-2016-000571","article-title":"The systolic paradox in hypertrophic cardiomyopathy","volume":"4","author":"Haland","year":"2017","journal-title":"Open Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib59","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe Registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ehjci\/jeu313","article-title":"Accuracy of cardiac CT, radionucleotide and invasive ventriculography, two- and three-dimensional echocardiography, and SPECT for left and right ventricular ejection fraction compared with cardiac MRI: a meta-analysis","volume":"16","author":"Pickett","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib61","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjcard.2017.05.039","article-title":"Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy","volume":"120","author":"Liu","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib62","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/heartjnl-2015-308576","article-title":"Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy","volume":"102","author":"Reant","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib63","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jacc.2005.10.061","article-title":"Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy","volume":"47","author":"Serri","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib64","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.echo.2017.11.002","article-title":"Rest and stress longitudinal systolic left ventricular mechanics in hypertrophic cardiomyopathy: implications for prognostication","volume":"31","author":"Pozios","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib65","doi-asserted-by":"crossref","first-page":"e0221061","DOI":"10.1371\/journal.pone.0221061","article-title":"Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy","volume":"14","author":"Neisius","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.echo.2022.03.012_bib66","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2018180339","article-title":"Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: cardiac MR feature tracking","volume":"290","author":"Vigneault","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.echo.2022.03.012_bib67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00247-019-04549-4","article-title":"Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy","volume":"50","author":"Li","year":"2020","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib68","article-title":"The role of speckle tracking echocardiography in the evaluation of common inherited cardiomyopathies in children and adolescents: a systematic review","volume":"11","author":"Dorobantu","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.echo.2022.03.012_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.echo.2013.10.012","article-title":"Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging","volume":"27","author":"Forsey","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib70","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(96)00315-4","article-title":"Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study","volume":"28","author":"Nishimura","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib71","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.CIR.99.2.254","article-title":"Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy","volume":"99","author":"Nagueh","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib72","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.107.698985","article-title":"Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization","volume":"116","author":"Geske","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mri.2018.08.018","article-title":"Mitral annular velocity measurement with cardiac magnetic resonance imaging using a novel annular tracking algorithm: Validation against echocardiography","volume":"55","author":"Thavendiranathan","year":"2019","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejrad.2010.12.036","article-title":"Estimation of the left ventricular diastolic function with cardiac MDCT: correlation of the slope of the time-enhancement-curve with the mitral annulus diastolic velocity","volume":"81","author":"Nakahara","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/heart.87.3.247","article-title":"Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity","volume":"87","author":"Matsumura","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib77","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000124723.16433.31","article-title":"Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy","volume":"109","author":"McMahon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.echo.2008.11.001","article-title":"Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy","volume":"22","author":"Losi","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib79","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib80","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2006.05.013","article-title":"Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)","volume":"98","author":"Nistri","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005706","article-title":"Global longitudinal strain and left atrial volume index provide incremental prognostic value in patients with hypertrophic cardiomyopathy","volume":"10","author":"Hiemstra","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib82","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004052","article-title":"Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation","volume":"10","author":"Debonnaire","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.echo.2022.03.012_bib83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.echo.2019.01.007","article-title":"Low left atrial strain is associated with adverse outcomes in hypertrophic cardiomyopathy patients","volume":"32","author":"Vasquez","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib84","doi-asserted-by":"crossref","first-page":"e0245934","DOI":"10.1371\/journal.pone.0245934","article-title":"Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study","volume":"16","author":"Tayal","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.echo.2022.03.012_bib85","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jacep.2018.10.016","article-title":"Hypertrophic cardiomyopathy patients with paroxysmal atrial fibrillation have a high burden of left atrial fibrosis by cardiac magnetic resonance imaging","volume":"5","author":"Sivalokanathan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.echo.2022.03.012_bib86","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCIMAGING.112.000175","article-title":"Interpretation of left ventricular diastolic dysfunction in children with cardiomyopathy by echocardiography: problems and limitations","volume":"6","author":"Dragulescu","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib87","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.echo.2021.04.014","article-title":"Left atrial strain and function in pediatric hypertrophic cardiomyopathy","volume":"34","author":"Jhaveri","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib88","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcmg.2017.08.018","article-title":"Myocardial stiffness assessment using shear wave imaging in pediatric hypertrophic cardiomyopathy","volume":"11","author":"Villemain","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib89","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jcmg.2017.07.016","article-title":"Role of exercise testing in hypertrophic cardiomyopathy","volume":"10","author":"Rowin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/heart.86.6.709","article-title":"Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy","volume":"86","author":"Wigle","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2022.03.012_bib93","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.echo.2022.03.012_bib94","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2009.11.016","article-title":"Significance of postprandial symptom exacerbation in hypertrophic cardiomyopathy","volume":"105","author":"Adams","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/clc.20594","article-title":"Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy","volume":"32","author":"Geske","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib96","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0002-9149(81)90605-6","article-title":"Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: proposed role in systolic anterior motion of mitral valve","volume":"48","author":"Shah","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib97","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-8703(87)90701-0","article-title":"An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations","volume":"113","author":"Jiang","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib98","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2009.03.052","article-title":"Reflections of inflections in hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib99","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/hrt.2007.118018","article-title":"Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"94","author":"Kwon","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib100","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.84.3.1188","article-title":"Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction","volume":"84","author":"Klues","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib101","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pcad.2012.03.002","article-title":"Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy","volume":"54","author":"Cavalcante","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.echo.2022.03.012_bib102","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.echo.2016.03.003","article-title":"Abnormalities of the mitral apparatus in hypertrophic cardiomyopathy: echocardiographic, pathophysiologic, and surgical insights","volume":"29","author":"Silbiger","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib103","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jacc.2006.07.065","article-title":"Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy","volume":"48","author":"Nagueh","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib104","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198501313120504","article-title":"Hypertensive hypertrophic cardiomyopathy of the elderly","volume":"312","author":"Topol","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2022.03.012_bib105","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/CCM.0b013e3181958710","article-title":"Unexplained hypotension: the spectrum of dynamic left ventricular outflow tract obstruction in critical care settings","volume":"37","author":"Chockalingam","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.echo.2022.03.012_bib106","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0735-1097(99)00464-7","article-title":"Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease","volume":"34","author":"Maslow","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib107","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcmg.2016.01.005","article-title":"Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the neo-LVOT","volume":"10","author":"Blanke","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib108","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jcmg.2008.09.002","article-title":"Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies","volume":"1","author":"Afonso","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib109","doi-asserted-by":"crossref","first-page":"iii9","DOI":"10.1093\/ejechocard\/jep157","article-title":"Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management","volume":"10","author":"Williams","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0002-9149(80)90133-2","article-title":"Hypertrophic cardiomyopathy: subclassification by m mode echocardiography","volume":"45","author":"Gilbert","year":"1980","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib111","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/hrt.37.9.917","article-title":"Hypertrophic obstructive cardiomyopathy. Assessment by echocardiographic and Doppler ultrasound techniques","volume":"37","author":"Boughner","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib112","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0894-7317(97)70112-3","article-title":"Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy--the lobster claw abnormality","volume":"10","author":"Sherrid","year":"1997","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0735-1097(92)90057-T","article-title":"Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy","volume":"19","author":"Panza","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.echo.2020.08.019","article-title":"Three-dimensional imaging and dynamic modeling of systolic anterior motion of the mitral valve","volume":"34","author":"Vainrib","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib116","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.65.2.399","article-title":"Mechanism of early systolic closure of the aortic valve in discrete membranous subaortic stenosis","volume":"65","author":"Sabbah","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib117","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/HCO.0000000000000425","article-title":"Imaging adult patients with discrete subvalvar aortic stenosis","volume":"32","author":"Opotowsky","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib118","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0003-4975(99)00447-6","article-title":"Fixed left ventricular outflow tract obstruction in presumed hypertrophic obstructive cardiomyopathy: implications for therapy","volume":"68","author":"Bruce","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.echo.2022.03.012_bib119","doi-asserted-by":"crossref","first-page":"1009 e5","DOI":"10.1016\/j.echo.2007.01.015","article-title":"Not all systolic velocities indicate obstruction in hypertrophic cardiomyopathy: a simultaneous Doppler catheterization study","volume":"20","author":"Jaber","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: A focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"30","author":"Baumgartner","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib121","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/CIRCIMAGING.113.000575","article-title":"Limitations of Doppler echocardiography in the evaluation of serial stenoses","volume":"6","author":"Scantlebury","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib122","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.echo.2018.01.022","article-title":"Standardized goal-directed Valsalva maneuver for assessment of inducible left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"31","author":"Kumar","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib123","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.echo.2020.01.020","article-title":"Value of exercise stress echocardiography in children with hypertrophic cardiomyopathy","volume":"33","author":"El Assaad","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib124","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.98.9.856","article-title":"Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: mismatch of posterior to anterior leaflet length and mobility","volume":"98","author":"Schwammenthal","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib125","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0735-1097(00)01019-6","article-title":"Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy","volume":"36","author":"Yu","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib126","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.echo.2018.10.011","article-title":"Accuracy of jet direction on Doppler echocardiography in identifying the etiology of mitral regurgitation in obstructive hypertrophic cardiomyopathy","volume":"32","author":"Hang","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib127","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2011.02.033","article-title":"Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy","volume":"57","author":"Minami","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9149(73)90802-3","article-title":"Diffuse muscular subaortic stenosis: surgical treatment","volume":"31","author":"Cooley","year":"1973","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib129","first-page":"783","article-title":"Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy","volume":"91","author":"Malcolmson","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.echo.2022.03.012_bib130","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib131","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1540-8175.2009.00905.x","article-title":"Severe symptoms in mid and apical hypertrophic cardiomyopathy","volume":"26","author":"Shah","year":"2009","journal-title":"Echocardiography"},{"key":"10.1016\/j.echo.2022.03.012_bib132","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0002-8703(88)90730-2","article-title":"Mid-cavity obstruction in apical hypertrophy: Doppler evidence of diastolic intraventricular gradient with higher apical pressure","volume":"116","author":"Zoghbi","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib133","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib134","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.athoracsur.2013.04.073","article-title":"Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy","volume":"96","author":"Kunkala","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.echo.2022.03.012_bib136","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib137","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/CIRCIMAGING.112.976738","article-title":"Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy","volume":"5","author":"Dass","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib138","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib139","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1007\/s00330-017-4869-x","article-title":"Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR","volume":"27","author":"Avanesov","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10554-017-1252-6","article-title":"High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy","volume":"34","author":"Gommans","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib141","doi-asserted-by":"crossref","first-page":"1980636","DOI":"10.1155\/2016\/1980636","article-title":"Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy","volume":"2016","author":"Compton","year":"2016","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.echo.2022.03.012_bib142","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijcard.2011.01.096","article-title":"Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT","volume":"158","author":"Yajima","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib143","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10554-017-1115-1","article-title":"Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement","volume":"33","author":"Spartera","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib144","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib145","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib146","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib147","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2022.03.012_bib148","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib149","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.echo.2005.06.011","article-title":"Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity","volume":"18","author":"Yang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib150","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib151","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.echo.2009.09.016","article-title":"Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy","volume":"22","author":"Yang","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib152","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib153","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","article-title":"Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Gimeno","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib154","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijcard.2017.04.039","article-title":"Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy","volume":"243","author":"Lu","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib155","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jtcvs.2015.07.063","article-title":"Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: Relationship to outcomes","volume":"150","author":"Desai","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.echo.2022.03.012_bib156","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jjcc.2014.02.011","article-title":"Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography","volume":"64","author":"Ichida","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib157","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/RTI.0000000000000115","article-title":"Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy","volume":"29","author":"Hanneman","year":"2014","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib158","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib159","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib161","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib162","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","article-title":"Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"106","author":"Olivotto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib163","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib164","doi-asserted-by":"crossref","first-page":"e005372","DOI":"10.1161\/CIRCIMAGING.116.005372","article-title":"How to image hypertrophic cardiomyopathy","volume":"10","author":"Maron","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2022.03.012_bib166","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib167","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1148\/radiol.10090526","article-title":"Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging","volume":"258","author":"Harrigan","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.echo.2022.03.012_bib168","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.amjcard.2018.01.022","article-title":"Stress myocardial blood flow heterogeneity is a positron emission tomography biomarker of ventricular arrhythmias in patients with hypertrophic cardiomyopathy","volume":"121","author":"Lu","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib169","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.71.2.234","article-title":"Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures","volume":"71","author":"Cannon","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.97.3.230","article-title":"Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation","volume":"97","author":"Krams","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib171","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\"small vessel\") coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib172","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death","volume":"30","author":"Basso","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib173","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jcct.2014.09.007","article-title":"Utility of coronary CT angiography in outpatients with hypertrophic cardiomyopathy presenting with angina symptoms","volume":"8","author":"Shariat","year":"2014","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.echo.2022.03.012_bib174","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.amjcard.2020.02.002","article-title":"Frequency and significance of coronary artery disease and myocardial bridging in patients with hypertrophic cardiomyopathy","volume":"125","author":"van der Velde","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib175","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.eurheartj.a015002","article-title":"Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study","volume":"17","author":"Elliott","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib176","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib177","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0735-1097(98)00036-9","article-title":"Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia","volume":"31","author":"Schwartzkopff","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib178","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2016.06.044","article-title":"Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry","volume":"219","author":"Ciampi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib179","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.amjcard.2008.08.023","article-title":"Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy","volume":"102","author":"Cortigiani","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib180","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.echo.2017.05.017","article-title":"A comprehensive review of stress testing in hypertrophic cardiomyopathy: assessment of functional capacity, identification of prognostic indicators, and detection of coronary artery disease","volume":"30","author":"Tower-Rader","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib181","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.echo.2011.11.005","article-title":"Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy","volume":"25","author":"Peteiro","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib182","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.76.6.1214","article-title":"Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography","volume":"76","author":"O'Gara","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib183","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.83.5.1660","article-title":"Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy","volume":"83","author":"Cannon","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib184","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0735-1097(93)90193-5","article-title":"Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy","volume":"22","author":"Dilsizian","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib185","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/01.CIR.79.5.1052","article-title":"Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy","volume":"79","author":"Udelson","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib186","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.CIR.85.3.1039","article-title":"Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy","volume":"85","author":"Cannon","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib187","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ehjci\/jes242","article-title":"Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography","volume":"14","author":"Timmer","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib188","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00259-016-3603-2","article-title":"Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a (13)NH3 gated PET study","volume":"44","author":"Sciagra","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib189","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s12350-015-0158-8","article-title":"Apparent left ventricular cavity dilatation during PET\/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms","volume":"23","author":"Bravo","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib190","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.nuclcard.2006.05.018","article-title":"Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study","volume":"13","author":"Knaapen","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib191","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2967\/jnumed.111.096156","article-title":"PET\/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"53","author":"Bravo","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.echo.2022.03.012_bib192","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-B","article-title":"Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography","volume":"17","author":"Camici","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib193","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2022.03.012_bib194","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/heartjnl-2019-315848","article-title":"Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy","volume":"106","author":"Camaioni","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.echo.2022.03.012_bib195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12968-020-00623-1","article-title":"Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy","volume":"22","author":"Kim","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2022.03.012_bib196","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ehjci\/jeu225","article-title":"Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy","volume":"16","author":"Peteiro","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib197","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12968-018-0462-y","article-title":"Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects","volume":"20","author":"Brown","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2022.03.012_bib198","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12968-017-0388-9","article-title":"Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography","volume":"19","author":"Engblom","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.echo.2022.03.012_bib199","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","article-title":"Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging","volume":"115","author":"Petersen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib200","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1007\/s00330-018-5951-8","article-title":"Clinical significance of evaluating coronary atherosclerosis in adult patients with hypertrophic cardiomyopathy who have chest pain","volume":"29","author":"Shin","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib201","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00330-014-3465-6","article-title":"Diagnostic performance of computed tomography for detection of concomitant coronary disease in hypertrophic cardiomyopathy","volume":"25","author":"Zhao","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.echo.2022.03.012_bib202","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jcct.2018.08.002","article-title":"Hypertrophic Cardiomyopathy (HCM): New insights into Coronary artery remodelling and ischemia from FFRCT","volume":"12","author":"Sellers","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.echo.2022.03.012_bib203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcct.2015.12.006","article-title":"Coronary CT angiography derived fractional flow reserve: Methodology and evaluation of a point of care algorithm","volume":"10","author":"Coenen","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.echo.2022.03.012_bib204","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.111.039255","volume":"124","author":"Cheng","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib205","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjci\/jey182","article-title":"Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial","volume":"20","author":"Foldyna","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib206","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/eurheartj\/ehr014","article-title":"A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension","volume":"32","author":"Genders","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib207","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.amjcard.2009.07.011","article-title":"Comparison of the value of coronary calcium detection to computed tomographic angiography and exercise testing in patients with chest pain","volume":"104","author":"Nieman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1148\/radiol.13122529","article-title":"Coronary artery calcium scoring to exclude flow-limiting coronary artery disease in symptomatic stable patients at low or intermediate risk","volume":"269","author":"Mouden","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.echo.2022.03.012_bib209","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.jacc.2012.05.062","article-title":"Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures: results from the multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter) registry","volume":"60","author":"Shaw","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib210","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10554-013-0267-x","article-title":"Prevalence and predictors of coronary artery disease in patients with a calcium score of zero","volume":"29","author":"de Carvalho","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib211","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamacardio.2016.5670","article-title":"The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet Study","volume":"2","author":"Ho","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib212","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib213","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib214","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","article-title":"Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2022.03.012_bib215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.CIR.0000084500.72232.8D","article-title":"Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease","volume":"108","author":"Nagueh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib216","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib217","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0735-1097(95)00573-0","article-title":"Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy","volume":"27","author":"Gadler","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.echo.2022.03.012_bib218","first-page":"iii88","article-title":"Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization","volume":"10","author":"Barold","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.echo.2022.03.012_bib219","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.echo.2017.11.016","article-title":"Intraoperative two- and three-dimensional transesophageal echocardiography in combined myectomy-mitral operations for hypertrophic cardiomyopathy","volume":"31","author":"Nampiaparampil","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0003-4975(94)92268-3","article-title":"Extended myectomy for hypertrophic obstructive cardiomyopathy","volume":"58","author":"Messmer","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.echo.2022.03.012_bib221","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.echo.2020.03.002","volume":"33","author":"Nicoara","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib222","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0003-4975(02)04546-0","article-title":"Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction","volume":"75","author":"Sherrid","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.echo.2022.03.012_bib223","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0735-1097(98)00220-4","article-title":"Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy","volume":"32","author":"Nagueh","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2022.03.012_bib224","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/01.CIR.98.22.2415","article-title":"Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography","volume":"98","author":"Faber","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2022.03.012_bib225","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1067\/mje.2000.108250","article-title":"Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring","volume":"13","author":"Faber","year":"2000","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2022.03.012_bib226","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/euhj.1999.1692","volume":"20","author":"Kuhn","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2022.03.012_bib227","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0735-1097(00)01045-7","article-title":"Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy","volume":"37","author":"Flores-Ramirez","year":"2001","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American Society of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731722001407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731722001407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:09:22Z","timestamp":1760245762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0894731722001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":227,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0894731722001407"],"URL":"https:\/\/doi.org\/10.1016\/j.echo.2022.03.012","relation":{},"ISSN":["0894-7317"],"issn-type":[{"value":"0894-7317","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Echocardiography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.echo.2022.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"2022 Published by Elsevier Inc. on behalf of the American Society of Echocardiography.","name":"copyright","label":"Copyright"}]}}